NatureWise Biotech & Medicals Corporation (4732) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for NatureWise Biotech & Medicals Corporation (4732:TWSE), powered by AI.

Current Price
$17.70
Sector
Healthcare
What is the NatureWise Biotech & Medicals Corporation stock price forecast?

NatureWise Biotech & Medicals Corporation is currently trading at $17.70. View real-time AI analysis on Alpha Lenz.

What is NatureWise Biotech & Medicals Corporation insider trading activity?

View the latest insider trading data for NatureWise Biotech & Medicals Corporation on Alpha Lenz.

What is NatureWise Biotech & Medicals Corporation's P/E ratio?

View NatureWise Biotech & Medicals Corporation's valuation metrics on Alpha Lenz.

NatureWise Biotech & Medicals Corporation

TWSE · 4732
NT$17.70-0.50(-2.75%)
Ask about NatureWise Biotech & Medicals Corporation's future dividend policy...
Alpha Chat Insight

NatureWise Biotech & Medicals Corporation's ROE is -13.5%. Explore profitability and growth together.

Ask for details

Company Overview

NatureWise Biotech & Medicals Corporation is a Taiwan-based biotechnology company specializing in the research, development, and commercialization of therapeutic drugs and nutraceuticals. Its primary focus lies in developing pharmaceutical products for both preventive and therapeutic use, notably including LipoCol Forte, a capsule addressing hypercholesterolemia and hypertriglyceridemia, as well as NBM-BMX, an oral softgel formulated for cancer treatment. The company also markets health supplements such as PPL Taiwan green propolis. Operating within the pharmaceuticals and medical research sector, NatureWise serves primarily the Taiwanese market but also records sales across other Asian countries such as Mainland China, Japan, Singapore, and Malaysia. Founded in 2000 and headquartered in Taipei, the organization supports both Western and Chinese medicine, reflecting a diverse approach to healthcare solutions. With a lean team of around 32 employees, NatureWise Biotech & Medicals Corporation plays a notable role in Taiwan's life sciences ecosystem, focusing on innovation in pharmaceuticals and contributing to global healthcare developments.

SectorHealthcare
IndustryBiotechnology
0

Company Statistics

FY 2025

Profile

N/AMarket Cap
NT$176.77MRevenue
0.00Shares Out
0Employees

Margins

48.48%Gross
-51.14%EBITDA
-60.45%Operating
-57.44%Pre-Tax
-67.00%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

-8.21%Rev 3Yr
-10.45%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-15.25%ROA
-13.52%ROE
-13.06%ROIC

Financial Health

NT$97.68MCash & Cash Equivalents
NT$-25.59MNet Debt
11.25%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

NatureWise Biotech & Medicals Corporation (ticker: 4732) is a company listed on TWSE in the Healthcare sector (Biotechnology).

The current price is 17.7 with a P/E ratio of -x and P/B of -x.

ROE is -13.52% and operating margin is -60.45%. Annual revenue is $177M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
NatureWise Biotech & Medicals Corporation (4732) Stock Forecast 2026 $17.70 — Price, Financials & Analyst Targets | Alpha Lenz